BURLINGTON Mass. Dec. 8 2011 PRNewswire &160;Coronado Biosciences Inc. OTCBB CNDO a biopharmaceutical company focused on the development of novel immunotherapy agents for the treatment of autoimmune diseases and cancer today announced that an oral pres...
↧